SCHEMBL4426458

SCHEMBL4426458

CCCC(C)(O)CC(C)C

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MMP8 P22894 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL42225 0.86 ALDH1A1 (0.37) ALDH1A1
SCHEMBL5464467 0.85 FDPS (0.31) FDPS
SCHEMBL1245105 0.83 FDPS (0.39) FDPS
SCHEMBL2452262 0.82 TSHR (0.36) FDPSALDH1A1
SCHEMBL8366685 0.81
SCHEMBL8388625 0.81 FDPS (0.41) FDPS
SCHEMBL22782920 0.80 FDPS (0.34) FDPS
SCHEMBL809181 0.80 TSHR (0.35) ALDH1A1MMP8
SCHEMBL14244404 0.80 TSHR (0.39)
SCHEMBL7241793 0.79 TSHR (0.33) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3212627-B1 PART-STREAM DISTILLATION BASF SE (DE) 2019-09-25 EP claimed
CN-119563915-A Method for improving quality of reconstituted tobacco 云南中烟工业有限责任公司 2025-03-07 CN disclosed
US-20240410055-A1 METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS MERCK PATENT GMBH (DE) 2024-12-12 US disclosed
CN-118076767-A Method and formulation for producing an optical metal oxide layer 默克专利有限公司 2024-05-24 CN disclosed
WO-2023057401-A1 METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS MERCK PATENT GMBH (DE) 2023-04-13 WO disclosed
EP-2964630-B9 PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL MYERS SQUIBB CO (US) 2017-08-09 EP disclosed
EP-2964630-B1 PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL MYERS SQUIBB CO (US) 2017-05-10 EP disclosed
EP-2812321-B1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL MYERS SQUIBB CO (US) 2016-01-06 EP disclosed
WO-2013119542-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL-MYERS SQUIBB COMPANY (US) 2013-08-15 WO disclosed
EP-1531781-B1 HAIR TREATMENT METHOD WITH HYDROXY COMPOUNDS UNILEVER NV (NL) 2009-01-28 EP disclosed
US-20070128139-A1 Hair treatment compositions comprising hydroxy comopounds UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2007-06-07 US disclosed
EP-1531781-A1 HAIR TREATMENT COMPOSITIONS COMPRISING HYDROXY COMPOUNDS UNILEVER N.V. (NL) 2005-05-25 EP disclosed
WO-2004006875-A1 HAIR TREATMENT COMPOSITIONS COMPRISING HYDROXY COMPOUNDS UNILEVER N.V. (NL) 2004-01-22 WO disclosed
US-4315989-A PRODUCING ANTIBIOTIC C14919 TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1982-02-16 US disclosed
US-4245047-A MICROBIOCIDE AND ANTITUMOR AGENT ANTIBIOTIC C 14919 E-1 AND E-2 TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1981-01-13 US disclosed
US-4187292-A ANTIBIOTIC C-14919 E-1 AND/OR C-14919 E-2 TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1980-02-05 US disclosed
US-4111917-A POLYURETHANES W. R. GRACE & CO. (US) 1978-09-05 US disclosed